Family · Pharmaceutical analytical standards
Deferasirox
An iron chelator taken by mouth, approved in the United States in 2005: it removes the excess iron that builds up in patients receiving repeated transfusions, for example in beta-thalassaemia. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?Two of its molecules grip a single iron atom together; small and lipophilic, it can pull iron even from inside heart and liver cells.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
